About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
Is Marqeta a Good Software Stock to Buy Now?
Software company Marqeta (MQ) has forged several strategic partnerships since going public on June 9, 2021. So, let’s evaluate if it is wise to buy the dip in the stock now. Read on.
Should You Add Sirius XM Holdings Stock to Your Watchlist?
Audio company Sirius XM Holdings (SIRI) reported top-line and bottom-line growth in its last reported quarter. But can this stellar performance continue? Read on, let’s discuss.
Is Now a Good Time to Scoop Up Shares of Canopy Growth?
Shares of Canada-based cannabis company Canopy Growth (CGC) have declined significantly in price over the past few months. However, given that the company has recently introduced new products, is it wise to scoop up its shares now? Read on to learn our view.
Is General Motors a Good Stock to Own in 2022?
General Motors’ (GM) shares surged in price to hit their $67.21 all-time high on Jan. 5, 2022, after the company introduced its new EV at CES 2022. But is it wise to buy the stock now given that GM’s revenue declined in its last reported quarter? Read on to learn our view.
Up More Than 480% in 2021, is Vertex Energy Still a Buy?
Environmental services company Vertex Energy’s (VTNR) shares have soared nearly 485% in price over the past year on investors’ optimism surrounding its proposed acquisition of an oil refinery. But can the stock continue advancing despite several regulatory hurdles? Let’s find out. Read on.
Is Biolase a Good Medical Device Stock to Add to Your Portfolio?
Dental-industry-focused medical device company BIOLASE (BIOL) recently received an extension from Nasdaq to meet the exchange’s minimum bid price requirement and reported revenue growth in the third quarter. However, is it wise to add the stock to one’s portfolio even though BIOL reported losses in its last reported quarter? Read on to learn our view.
Up 1,650% in 2021, is Lightwave Logic Still a Buy?
Even though technology platform company Lightwave Logic (LWLG) has yet to generate sales, its shares have soared nearly 1,650% in price over the past year. So, do the shares have more upside to deliver? Let’s find out. Read on.
Is Biofrontera a Winner in the Biopharmaceutical Industry?
Biopharmaceutical company Biofrontera (BFRI) made its stock market debut on October 29, 2021, and hit its 52-week high of $14.63 on December 21, 2021. However, is it wise to buy the stock now despite the company being in its early stages of development? Let’s find out.
Down 80% From its Highs, is Now a Good Time to Scoop Up Shares of Robinhood Markets?
Financial services platform operator Robinhood Markets (HOOD) has been making several developments in the cryptocurrency space. So, with the stock down nearly 80% from its highs, is now a good time to buy the dip?